Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Other Long-Term Assets
$7,252 Mil (As of Sep. 2014)

GlaxoSmithKline PLC's other long-term assets for the quarter that ended in Sep. 2014 was $7,252 Mil.

GlaxoSmithKline PLC's quarterly other long-term assets increased from Mar. 2014 ($7,437 Mil) to Jun. 2014 ($7,766 Mil) but then declined from Jun. 2014 ($7,766 Mil) to Sep. 2014 ($7,252 Mil).

GlaxoSmithKline PLC's annual other long-term assets increased from Dec. 2011 ($7,157 Mil) to Dec. 2012 ($7,177 Mil) and increased from Dec. 2012 ($7,177 Mil) to Dec. 2013 ($7,412 Mil).


Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.

A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Other Long-Term Assets 5,9185,8237,0177,3496,4687,0667,9047,1577,1777,412

GlaxoSmithKline PLC Quarterly Data

Other Long-Term Assets 8,0098,3497,1777,2317,3987,5547,4127,4377,7667,252
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial